• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aeterna Zentaris Inc

+ Add to Watchlist

AEZ:CN

0.5900 CAD 0.0100 1.67%

As of 14:43:20 ET on 11/21/2014.

Snapshot for Aeterna Zentaris Inc (AEZ)

Open: 0.6200 Day's Range: 0.5900 - 0.6200 Volume: 46,823
Previous Close: 0.6000 52wk Range: 0.5500 - 1.7200 1-Yr Rtn: -46.36%

Stock Chart for AEZ

No chart data available.
  • AEZ:CN 0.5900
  • 1D
  • 1M
  • 1Y
0.6000
Interactive AEZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEZ

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -0.6200
Est. EPS (USD) (12/2014) -0.5500
Est. PEG Ratio -
Market Cap (M CAD) 37.71
Shares Outstanding (M) 63.91
30 Day Average Volume 144,029
Price/Book (mrq) 4.5334
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEZ

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval.

David A DoddPresident/CEODennis TurpinSenior VP/CFO
Philip A TheodoreSenior VP/CAO/Secy/Gen CnslJude DingesSenior VP/Chief Commercial Ofcr
More Company Profile & Key Executives for AEZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil